Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
atezolizumab (Tecentriq) (2 trials)
bevacizumab (avastin) (9 trials)
cetuximab (erbitux) (4 trials)
cisplatin (platinol) (10 trials)
docetaxel (taxotere) (1 trial)
Adenocarcinoma (Phase 3)
Adenoma, Islet Cell (Phase 3)
Anus Neoplasms (Phase 2)
Bile Duct Neoplasms (Phase 3)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Ductal (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Cholangiocarcinoma (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Endocrine Gland Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 2)
Gallbladder Neoplasms (Phase 3)
Gastrointestinal Neoplasms (Phase 2)
Liver Neoplasms (Phase 3)
Malignant Carcinoid Syndrome (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Second Primary (Phase 2)
Neuroendocrine Tumors (Phase 3)
Neutropenia (Phase 2)
Pancreatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Stomach Neoplasms (Phase 3)